HIPAA 2020: Texting, Emailing, And Personal Devices - New Guidance

  • Check with publisher
  • Published date: July 6, 2020
    • Fremont, California, United States


Professional communications involving Protected Health Information must be conducted securely, according to guidance from HHS and any reasonable Risk Analysis required by the Security Rule, so any office communications must be carefully controlled to avoid breaches of PHI.

But it's not only the office staff and physicians who need to communicate, communications with patients is a key part of patient care today.

As HIPAA requirements for allowing patients electronic access to their health information are now in effect, and as patients increasingly come to depend on electronic communications, there are new demands for communication via e-mail and texting, using personal devices.

Patients don't want to bother with secure Web-site-based solutions, they just want to use the tools they already use for communication, and they have a right to communicate how they wish. How can HIPAA requirements for privacy and security be reconciled with patient requests for information provided by e-mail and text messages? This session will discuss the differences between professional communications and patient communications, and how they must be treated to best serve patients, most efficiently enable communications, and remain within the bounds of HIPAA compliance.


Roger Steven
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • EU Regulatory Affairs strategy during development of medicinal products

    EU Regulatory Affairs strategy during development of medicinal products

    Clinical/Medical Sciences Fremont (California) December 30, 2020 Check with publisher

    The main document from a regulatory perspective in the development of a medicinal product is the regulatory plan. In this Seminar it is explained how to write the regulatory plan, and which aspects to consider. The regulatory plan describes the regul...

  • 6-Hour Virtual Seminar - Medical Claims Boot Camp

    6-Hour Virtual Seminar - Medical Claims Boot Camp

    Clinical/Medical Sciences Fremont (California) December 29, 2020 Check with publisher

    Statistics is a useful decision making tool in the clinical research arena. When working in a field where a p-value can determine the next steps on development of a drug or procedure, it is imperative that decision makers understand the theory and ap...

  • 2021 ICD-10-CM Changes

    2021 ICD-10-CM Changes

    Clinical/Medical Sciences san Jose (california) November 28, 2020 Check with publisher

    Each year the Center for Medicare and Medicaid Services (CMS) approves updates to the ICD-10-CM of diagnosis codes to become effective for medical claims beginning on October 1st. The changes must be implemented by all medical providers in order to h...